Silencing MaxiK activity in corporal smooth muscle cells initiates compensatory mechanisms to maintain calcium homeostasis.
BACKGROUND
The MaxiK potassium channel is regulated by voltage and intracellular calcium, and plays a critical role in regulating intracellular calcium concentration ([Ca(2+) ](i)), which is the ultimate determinant of smooth muscle tone. Tight control of corpus cavernosum smooth muscle (CCSM) tone is critically important and misregulation can result in erectile dysfunction.


OBJECTIVE
Because of the tight functional linkage of MaxiK and calcium channel activity, the aim of this study was to determine the effects of silencing and pharmacological inhibition of MaxiK on calcium homeostasis and intercellular calcium signaling in CCSM cells.


METHODS
We compared changes in the basal intracellular [Ca(2+) ](i) and parameters defining intercellular calcium wave (ICW) spread in 48 hours MaxiK silenced CCSM cells vs. acute blockade of the channel with iberiotoxin. To analyze changes occurring in gene expression we performed micro-array analysis following MaxiK silencing for 48 hours.


METHODS
Changes in Fura-2 fluorescence intensities were measured to evaluate basal [Ca(2+) ](i) levels and ICW parameters. Microarray analysis of global gene expression was performed.


RESULTS
Forty-eight hours after MaxiK silencing the basal [Ca(2+) ](i) , the ICW amplitude and spread among CCSM cells were not markedly different in silenced compared to mock transfected controls, whereas short-term blockade significantly increased basal [Ca(2+) ](i) level and amplified Ca(2+) signaling among CCSM cells. Micro-array analysis showed that several genes within Ca(2+) homeostasis and smooth muscle tone regulation pathways had significantly altered expression.


CONCLUSIONS
Our results indicate that while short-term blockade of the MaxiK channel is associated with an increase in basal [Ca(2+) ](i), Ca(2+) homeostasis is restored during the 48 hours period following silencing. We hypothesize that the different pathways regulating [Ca(2+) ](i) and CCSM tone are linked through molecular crosstalk and that their coordinated regulation is part of a compensatory mechanism aimed to maintain Ca(2+) homeostasis and CCSM tone.
Department of Urology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
Giulia
G
Calenda
Sylvia Ottilie
SO
Suadicani
Rodolfo
R
Iglesias
David Conover
DC
Spray
Arnold
A
Melman
Kelvin Paul
KP
Davies
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D015870:Gene Expression; D020869:Gene Expression Profiling; D006706:Homeostasis; D006801:Humans; D066298:In Vitro Techniques; D051036:Large-Conductance Calcium-Activated Potassium Channels / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D008297:Male; D032389:Myocytes, Smooth Muscle / Q000378:metabolism*; D020411:Oligonucleotide Array Sequence Analysis; D010413:Penis / Q000378:metabolism*; D051381:Rats
D051036:Large-Conductance Calcium-Activated Potassium Channels; D002118:Calcium
EMBO J. 2004 Jun 2;23(11):2196-205
15141163
Can J Urol. 2005 Jun;12(3):2687-98; discussion 2699
16011816
Am J Physiol Lung Cell Mol Physiol. 2009 Aug;297(2):L347-61
19465516
Glia. 2004 Nov 15;48(3):217-29
15390120
Microcirculation. 1996 Sep;3(3):313-28
8930888
Nat Protoc. 2006;1(4):1799-809
17487162
J Androl. 2005 May-Jun;26(3):310-8
15866997
J Urol. 2002 Jul;168(1):355-61
12050569
Methods. 2001 Dec;25(4):402-8
11846609
Hum Gene Ther. 2006 Dec;17(12):1165-76
17134370
J Urol. 2009 May;181(5):2355-65
19303094
J Physiol. 2005 Sep 1;567(Pt 2):545-56
16020453
J Urol. 2003 Jul;170(1):285-90
12796707
Am J Physiol. 1992 Aug;263(2 Pt 1):C373-83
1325115
J Physiol. 2006 Jan 1;570(Pt 1):65-72
16239267
Biochem Pharmacol. 2000 Mar 15;59(6):713-7
10677588
BJU Int. 2005 Aug;96(3):257-80
16042713
Br J Pharmacol. 1991 Jul;103(3):1814-8
1718525
BJU Int. 2006 Aug;98(2):396-401
16879685
BJU Int. 2008 Sep;102(6):736-40
18410445
J Mol Cell Cardiol. 2008 Sep;45(3):347-62
18598701
J Pharmacol Exp Ther. 1985 Nov;235(2):267-73
2414429
Eur Urol. 2007 Oct;52(4):1229-37
17150299
J Urol. 2009 Jun;181(6):2806-15
19375734
FASEB J. 2007 Mar;21(3):812-22
17197382
J Androl. 1993 Sep-Oct;14(5):319-28
7507099
Eur Urol. 2005 Aug;48(2):314-8
15964135
Hum Genet. 1992 Sep-Oct;90(1-2):126-30
1427768
Int J Oncol. 2004 Aug;25(2):535-40
15254754
Eur Urol. 2009 Dec;56(6):1055-66
19167152
J Biol Chem. 2008 Jul 4;283(27):18505-12
18426792
J Urol. 1993 Jun;149(6):1568-75
8388962
Eur J Pharmacol. 1993 Apr 22;235(1):37-43
7686105
FEBS J. 2009 Mar;276(6):1680-97
19220851
Am J Physiol. 1998 Aug;275(2):H600-8
9683449
Gene Ther. 2008 Mar;15(5):364-70
18200069
Isr Med Assoc J. 2007 Mar;9(3):143-6
17402321
Glia. 1998 Sep;24(1):65-73
9700490
Science. 2003 Nov 21;302(5649):1416-8
14631046
Int J Mol Med. 2004 Aug;14(2):333-8
15254788
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):77-86
9459576
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1149-57
18701628
Nature. 1993 Jan 28;361(6410):315-25
8381210
J Sex Med. 2010 Jan;7(1 Pt 2):445-75
20092448
J Physiol. 2006 Jul 1;574(Pt 1):167-81
16644801
Am J Physiol. 1993 Jan;264(1 Pt 1):C80-92
8381593
BJU Int. 2007 Feb;99(2):418-430
17313427
Int J Impot Res. 2007 Jul-Aug;19(4):371-7
17287835
J Urol. 1995 Mar;153(3 Pt 1):818-25
7861546
Am J Physiol Cell Physiol. 2005 Jun;288(6):C1255-63
15677377
J Pharmacol Exp Ther. 1990 Nov;255(2):697-706
1700817
Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1544-53
15371262
Int J Impot Res. 1999 Aug;11(4):179-88
10467517
J Biol Chem. 2004 Aug 27;279(35):36445-53
15210719
Int J Impot Res. 1993 Jun;5(2):77-96
7688635